Tên IUPAC: sodium [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate
Số EC: 251-689-1
Khối lượng phân tử: 510.31
Công thức hoá học: C₁₄H₂₅N₄NaO₁₁P₂
Số CAS: 33818-15-4

Thông tin khác

Mô tả thêm:

Citicoline Sodium Injection (CAS 33818-15-4) is manufactured directly by Cisen Pharmaceutical Co., Ltd. to Chinese Pharmacopoeia (ChP) standards, supplied at a strength of 0.25 g per 2 mL. Its active ingredient is described as a nucleoside derivative that improves cerebral blood circulation and promotes brain function recovery, used for acute craniocerebral trauma and consciousness disturbance following brain surgery. Samples are available, and the product is distributed across a broad international market spanning the Americas, Europe, Australasia, Asia, the Middle East, and Africa.